Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|11|5|491-498

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.11, Iss.5, 2013-09, pp. : 491-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electrochemistry of Alzheimer Disease Amyloid Beta Peptides

By  

Current Medicinal Chemistry, Vol. 25, Iss. 33, 2018-10 ,pp. : 4066-4083

Bentham Science Publishers

Access to resources Recommend Favorite

Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer’s disease

By Posse de Chaves Elena  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 6, 2012-06 ,pp. : 753-764

NRC Research Press

Access to resources Recommend Favorite

Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1879-1904

Bentham Science Publishers

Access to resources Recommend Favorite

Amyloid-&bgr; Immunotherapy for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid &bgr;-peptides

By Larner A.J.   Rossor M.N.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1115-1127

Informa Healthcare

Access to resources Recommend Favorite